Multivariate analysis of predictors of long-term outcome
| . | HR . | 95% CI . | P . |
|---|---|---|---|
| MMR | 0.248 | 0.110-0.559 | .001 |
| MRD positive by IGH | 1.651 | 0.714-3.819 | .242 |
| MRD positive by flow | 1.464 | 0.583-3.679 | .418 |
| Positive CD20 | 0.486 | 0.211-1.118 | .090 |
| Fusion protein = p210 | 0.532 | 0.179-1.582 | .256 |
| Cytogenetics status; Ph+ alone or + other | 0.665 | 0.220-2.010 | .470 |
| Platelet count | 0.996 | 0.989-1.002 | .212 |
| Blast % BM | 0.984 | 0.962-1.007 | .162 |
| Age | 1.014 | 0.985-1.045 | .347 |
| Time to CR | 0.971 | 0.897-1.051 | .460 |
| log. WBC | 2.083 | 1.050-4.133 | .036 |
| . | HR . | 95% CI . | P . |
|---|---|---|---|
| MMR | 0.248 | 0.110-0.559 | .001 |
| MRD positive by IGH | 1.651 | 0.714-3.819 | .242 |
| MRD positive by flow | 1.464 | 0.583-3.679 | .418 |
| Positive CD20 | 0.486 | 0.211-1.118 | .090 |
| Fusion protein = p210 | 0.532 | 0.179-1.582 | .256 |
| Cytogenetics status; Ph+ alone or + other | 0.665 | 0.220-2.010 | .470 |
| Platelet count | 0.996 | 0.989-1.002 | .212 |
| Blast % BM | 0.984 | 0.962-1.007 | .162 |
| Age | 1.014 | 0.985-1.045 | .347 |
| Time to CR | 0.971 | 0.897-1.051 | .460 |
| log. WBC | 2.083 | 1.050-4.133 | .036 |